Brief Report on Use of Pembrolizumab With or Without Chemotherapy for Advanced Lung Cancer: A Real-World Analysis

Clin Lung Cancer. 2023 Jun;24(4):362-365. doi: 10.1016/j.cllc.2023.01.011. Epub 2023 Feb 8.

Authors

Affiliations

¹ Syapse, San Francisco, CA, USA. Electronic address: Monika.Izano@syapse.com.
² Syapse, San Francisco, CA, USA.
³ Cancer Service Line, Advocate Aurora Health, Milwaukee, WI, USA.
⁴ Ascension, Milwaukee, WI.
⁵ Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA.

PMID: 36863970
DOI: 10.1016/j.cllc.2023.01.011

No abstract available

Keywords: First line treatment; Immunotherapy; Metastatic lung cancer; Monoclonal antibodies; Non-small cell lung cancer.

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
B7-H1 Antigen
Carcinoma, Non-Small-Cell Lung* / drug therapy
Humans
Lung Neoplasms* / drug therapy

Substances

pembrolizumab
Antibodies, Monoclonal, Humanized
B7-H1 Antigen